Rotavirus vaccines: Current status and future considerations

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 6, 2014, Pages 1436-1448

  Yen, Catherine ^a   Tate, Jacqueline E ^a   Hyde, Terri B ^a   Cortese, Margaret M ^a   Lopman, Benjamin A ^a   Jiang, Baoming ^a   Glass, Roger I ^b   Parashar, Umesh D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Diarrhea; Gastroenteritis; Rotavirus; Rotavirus vaccines; Vaccine impact

Indexed keywords

ROTAVIRUS VACCINE;

DIARRHEA; DRUG DEVELOPMENT; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; ROTAVIRUS INFECTIONS; TRENDS;

DIARRHEA; DRUG DISCOVERY; HUMANS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84905845214     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28857     Document Type: Review

References (103)

1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, et al.; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-61; PMID:22579125; http://dx.doi.org/10.1016/S0140-6736(12)60560-1
2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD; WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41; PMID:22030330; http://dx.doi.org/10.1016/S1473-3099(11)70253-5
3. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72; PMID:12737740; http://dx.doi.org/10.3201/eid0905.020562
4. World Health Organization. Global rotavirus information and surveillance bulletin.2013; 7:1-11.
5. World Health Organization/United Nations Children's Fund. Ending preventable child deaths from pneumonia and diarrhoea by 2025: the integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). France: WHO Press; 2013.
6. World Health Organization. Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec 2013; 88:49-64; PMID:23424730
7. International Vaccine Access Center. VIMS report: global vaccine introduction. Johns Hopkins Bloomberg School of Public Health; March 2014. Available from: http://www.jhsph.edu/research/centers-and-institutes/ivac/vims/ IVAC-VIMS-Report-2014-Mar.pdf
8. PATH. Rotavirus vaccine introductions: worldwide. PATH; April 2014. Available from: http://sites.path.org/rotavirusvaccine/rotavirus-advocacy-and- communications-toolkit/country-introduction-maps-and-list/
9. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14; PMID:20692030; http://dx.doi.org/10.1016/S0140- 6736(10)60889-6
10. Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Van Doorn LJ, Muto H, Smolenov I, Suryakiran PV, Han HH. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine 2011; 29:6335-41; PMID:21640780; http://dx.doi.org/10.1016/j.vaccine.2011.05.017
11. Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, et al.; Human Rotavirus Vaccine Study Group. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-9; PMID:18395579; http://dx.doi.org/10.1016/S0140- 6736(08)60524-3
12. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98; PMID:20107214; http://dx.doi.org/10.1056/NEJMoa0904797
13. Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, Teoh YL, Tang H, Boudville I, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 2009; 27:5936-41; PMID:19679216; http://dx.doi.org/10. 1016/j.vaccine.2009.07.098
14. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434
15. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63; PMID:18037080; http://dx.doi.org/10.1016/S0140-6736(07)61744-9
16. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33; PMID:16394299; http://dx.doi.org/10.1056/NEJMoa052664
17. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23; PMID:20692031; http://dx.doi.org/10.1016/S0140-6736(10)60755-6
18. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009; 200(Suppl 1):S39-48; PMID:19817613; http://dx.doi.org/10.1086/605035
19. Patel M, Steele AD, Parashar UD. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine 2012; 30(Suppl 1):A30-5; PMID:22520134; http://dx.doi.org/10.1016/j.vaccine.2011.11. 093
20. Fu C, He Q, Xu J, Xie H, Ding P, Hu W, Dong Z, Liu X, Wang M. Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine 2012; 31:154-8; PMID:23127516; http://dx.doi.org/10. 1016/j.vaccine.2012.10.078
21. Dang DA, Nguyen VT, Vu DT, Nguyen TH, Nguyen DM, Yuhuan W, Baoming J, Nguyen DH, Le TL; Rotavin-M1 Vaccine Trial Group. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children. Vaccine 2012; 30(Suppl 1):A114-21; PMID:22520120; http://dx.doi.org/10.1016/j.vaccine.2011.07.118
22. Department of Biotechnology GoI. The need for rotavirus vaccines in India: understanding efficacy and impact. 2013; http://www.defeatdd.org/sites/ default/f iles/node-images/ROTAVAC%20efficacy%20fact%20sheet-FINAL.pdf. Accessed February 3, 2014.
23. Department of Biotechnology GoI. Internationl social innovation partnership leads to lifesaving vaccine. 2013; http://www.defeatdd.org/sites/ default/files/node-images/ROTAVAC%20history-FINAL-0.pdf. Accessed February 3, 2014.
24. World Health Organization. New vaccine post-introduction evaluation (PIE) tool. Geneva, Switzerland: WHO Document Services; 2010.
25. Personal communication with World Health Organization. Expanded Programme on Immunization.
26. Bayard V, DeAntonio R, Contreras R, Tinajero O, Castrejon MM, Ortega-Barría E, Colindres RE. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis 2012; 16:e94-8; PMID:22154592; http://dx.doi.org/10.1016/j. ijid.2011.09.003
27. do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Carmo EH, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011; 8:e1001024; PMID:21526228; http://dx.doi.org/10.1371/journal.pmed.1001024
28. Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, Colindres RE. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis 2011; 15:e206-10; PMID:21193339; http://dx.doi.org/10.1016/j.ijid.2010.11.007
29. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362:299-305; PMID:20107215; http://dx.doi.org/10.1056/NEJMoa0905211
30. Bégué RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics 2010; 126:e40-5; PMID:20587671; http://dx.doi.org/10.1542/peds.2009-2069
31. Chang HG, Smith PF, Tserenpuntsag B, Markey K, Parashar U, Morse DL. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine. Vaccine 2010; 28:754-8; PMID:19896451; http://dx.doi.org/10.1016/j.vaccine.2009.10.075
32. Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine 2011; 29:4663-7; PMID:21575665; http://dx.doi.org/10.1016/j.vaccine.2011.04.109
33. Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, Parashar UD. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365:1108-17; PMID:21992123; http://dx.doi.org/10.1056/ NEJMoa1000446
34. Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010; 29:489-94; PMID:20354464
35. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010; 201:1617-24; PMID:20402596; http://dx.doi.org/10. 1086/652403
36. Dey A, Wang H, Menzies R, Macartney K. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med J Aust 2012; 197:453-7; PMID:23072242; http://dx.doi.org/10.5694/ mja12.10062
37. Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126:e506-12; PMID:20732946; http://dx.doi.org/10.1542/peds.2010-0443
38. Gurgel RG, Bohland AK, Vieira SC, Oliveira DM, Fontes PB, Barros VF, Ramos MF, Dove W, Nakagomi T, Nakagomi O, et al. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology 2009; 137:1970-5; PMID:19632228; http://dx.doi.org/10.1053/j.gastro.2009.07.046
39. Lanzieri TM, Costa I, Shafi FA, Cunha MH, Ortega-Barria E, Linhares AC, Colindres RE. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr Infect Dis J 2010; 29:673-5; PMID:20300045; http://dx.doi.org/10.1097/INF.0b013e3181da8f23
40. Molto Y, Cortes JE, De Oliveira LH, Mike A, Solis I, Suman O, Coronado L, Patel MM, Parashar UD, Cortese MM. Reduction of diarrhea-associated hospitalizations among children aged < 5 Years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011; 30(Suppl):S16-20; PMID:21183835; http://dx.doi.org/10.1097/INF.0b013e3181fefc68
41. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico. Pediatr Infect Dis J 2011; 30(Suppl):S11-5; PMID:21183834; http://dx.doi.org/10.1097/INF.0b013e3181fefb32
42. Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30:e120-5; PMID:21436757; http://dx.doi.org/10.1097/INF.0b013e318214b811
43. Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, Racz ML. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J 2010; 29:1019-22; PMID:20543761
44. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30(Suppl):S6-10; PMID:21048524; http://dx.doi.org/10.1097/INF.0b013e3181fefa05
45. Yen C, Tate JE, Wenk JD, Harris JM 2nd, Parashar UD. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics 2011; 127:e9-15; PMID:21172995; http://dx.doi.org/10. 1542/peds.2010-1393
46. Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 2011; 127:e264-70; PMID:21262887; http://dx.doi.org/10. 1542/peds.2010-1830
47. Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30(Suppl):S25-9; PMID:21183837; http://dx.doi.org/10.1097/INF.0b013e3181fefdee
48. Custodio H, Masnita-Iusan C, Wludyka P, Rathore MH. Change in rotavirus epidemiology in northeast Florida after the introduction of rotavirus vaccine. Pediatr Infect Dis J 2010; 29:766-7; PMID:20661105; http://dx.doi.org/10.1097/ INF.0b013e3181dbf256
49. Eberly MD, Gorman GH, Eide MB, Olsen CH, Rajnik M. The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents. Vaccine 2011; 29:650-9; PMID:21129394; http://dx.doi.org/ 10.1016/j.vaccine.2010.11.041
50. Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur J Pediatr 2013; 172:739-46; PMID:23361964; http://dx.doi.org/10.1007/s00431-013-1945-3
51. Lambert SB, Faux CE, Hall L, Birrell FA, Peterson KV, Selvey CE, Sloots TP, Nissen MD, Grimwood K. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009; 191:157-60; PMID:19645646
52. Msimang VM, Page N, Groome MJ, Moyes J, Cortese M, Seheri M, Kahn K, Chagan M, Madhi SA, Cohen C. Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization Following Introduction into the South African Public Immunization Program. Pediatr Infect Dis J 2013; 32:1359-64; http://dx.doi.org/10.1097/INF.0b013e3182a72fc0; PMID:23934208
53. Paulke-Korinek M, Kollaritsch H, Aberle SW, Zwazl I, Schmidle-Loss B, Vécsei A, Kundi M. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine 2013; 31:2686-91; PMID:23597718; http://dx.doi.org/10.1016/j.vaccine.2013.04.001
54. Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29:2791-6; PMID:21320539; http://dx.doi.org/10.1016/j.vaccine. 2011.01.104
55. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J 2010; 29:319-23; PMID:19935446
56. Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, et al.; New Vaccine Surveillance Network (NVSN). Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis 2011; 53:245-53; PMID:21705316; http://dx.doi.org/10.1093/cid/cir307
57. Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, Parashar UD. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009; 124:465-71; PMID:19581260; http://dx.doi.org/10.1542/peds.2008-3528
58. Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, Novo L, Verstappen N, Van Ranst M, Matthijnssens J. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010; 28:7507-13; PMID:20851085; http://dx.doi.org/10.1016/j. vaccine.2010.09.004
59. Zlamy M, Kofler S, Orth D, Würzner R, Heinz-Erian P, Streng A, Prelog M. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis 2013; 13:112; PMID:23452879; http://dx.doi.org/10.1186/1471-2334-13- 112
60. Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, Meek J, Odofin L, Khizer S, Miller CA, et al. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics 2011; 128:e1474-81; PMID:22084328; http://dx.doi.org/10.1542/peds. 2011-1006
61. Gastañaduy PA, Curns AT, Parashar UD, Lopman BA. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA 2013; 310:851-3; PMID:23982372; http://dx.doi.org/10.1001/jama.2013.170800
62. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204:980-6; PMID:21878425; http://dx.doi.org/10.1093/infdis/ jir492
63. Anderson EJ, Shippee DB, Weinrobe MH, Davila MD, Katz BZ, Reddy S, Cuyugan MG, Lee SY, Simons YM, Yogev R, et al. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis 2013; 56:755-60; PMID:23349228; http://dx.doi.org/10.1093/cid/cis1010
64. Adlhoch C, Hoehne M, Littmann M, Marques AM, Lerche A, Dehnert M, Eckmanns T, Wichmann O, Koch J. Rotavirus vaccine effectiveness and casecontrol study on risk factors for breakthrough infections in Germany, 2010-2011. Pediatr Infect Dis J 2013; 32:e82-9; PMID:23334342; http://dx.doi.org/10.1097/INF. 0b013e3182720b71
65. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:e199-207; PMID:20083525; http://dx.doi.org/10.1542/peds.2009-1021
66. Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 2010; 29:1133-5; PMID:20634776; http://dx.doi.org/10.1097/INF.0b013e3181ed18ab
67. Braeckman T, Van Herck K, Meyer N, Pirçon JY, Soriano- Gabarró M, Heylen E, Zeller M, Azou M, Capiau H, De Koster J, et al.; RotaBel Study Group. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ 2012; 345:e4752; PMID:22875947; http://dx.doi.org/10.1136/bmj.e4752
68. Castilla J, Beristain X, Martínez-Artola V, Navascués A, García Cenoz M, Alvarez N, Polo I, Mazón A, Gil-Setas A, Barricarte A. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 2012; 30:539-43; PMID:22122860; http://dx.doi.org/10.1016/j.vaccine.2011.11.071
69. Chang WC, Yen C, Wu FT, Huang YC, Lin JS, Huang FC, Yu HT, Chi CL, Lin HY, Tate JE, et al. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants. Pediatr Infect Dis J 2014; 33:e81-6; http://dx.doi.org/10.1097/INF.0000000000000105; PMID:24569388
70. Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010; 201:363-9; PMID:20047501; http://dx.doi.org/10.1086/649843
71. Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013; 132:e25-33; PMID:23776114; http://dx.doi.org/10.1542/peds.2012-3804
72. Desai SN, Esposito DB, Shapiro ED, Dennehy PH, Vázquez M. Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. Vaccine 2010; 28:7501-6; PMID:20851087; http://dx.doi.org/10.1016/j.vaccine.2010.09.013
73. Donauer S, Payne DC, Edwards KM, Szilagyi PG, Hornung RW, Weinberg GA, Chappell J, Hall CB, Parashar UD, Staat MA. Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs. Vaccine 2013; 31:2692-7; PMID:23583814; http://dx.doi.org/10.1016/j.vaccine.2013.03.072
74. Gagneur A, Nowak E, Lemaitre T, Segura JF, Delaperrière N, Abalea L, Poulhazan E, Jossens A, Auzanneau L, Tran A, et al.; IVANHOE investigators. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study. Vaccine 2011; 29:3753-9; PMID:21443962; http://dx.doi.org/10. 1016/j.vaccine.2011.03.035
75. Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, et al. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J 2011; 30:396-401; PMID:21150692; http://dx.doi.org/10.1097/INF.0b013e3182055cc2
76. Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, Sánchez Lastres JM, Pértega Díaz S, Seoane Pillado MT, Martinón Sánchez JM; ROTACOST research team. Effectiveness of rotavirus vaccination in Spain. Hum Vaccin 2011; 7:757-61; PMID:21521947; http://dx.doi.org/10.4161/hv.7.7.15576
77. Muhsen K, Shulman L, Kasem E, Rubinstein U, Shachter J, Kremer A, Goren S, Zilberstein I, Chodick G, Ephros M, et al. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study. Hum Vaccin 2010; 6:450-4; PMID:20448471; http://dx.doi.org/10.4161/hv.6.6.11759
78. Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan R, Azimi PH, Harrison C, Moffatt M, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis 2013; 57:13-20; PMID:23487388;. http://dx.doi.org/10.1093/cid/cit164
79. Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia. Clin Infect Dis 2011; 52:191-9; PMID:21288843; http://dx.doi.org/10.1093/cid/ ciq101
80. Snelling TL, Schultz R, Graham J, Roseby R, Barnes GL, Andrews RM, Carapetis JR. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. Clin Infect Dis 2009; 49:428-31; PMID:19566443; http://dx.doi.org/10.1086/600395
81. Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, Griffin MR, Hall CB, Curns AT, Gentsch JR, et al.; New Vaccine Surveillance Network (NVSN). Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011; 128:e267-75; PMID:21768317; http://dx.doi.org/10.1542/ peds.2010-3722
82. Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010; 125:e208-13; PMID:20100757; http://dx.doi.org/10.1542/ peds.2009-1246
83. Yen C, Figueroa JR, Uribe ES, Carmen-Hernández LD, Tate JE, Parashar UD, Patel MM, Richardson López-Collado V. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. J Infect Dis 2011; 204:783-6; PMID:21810915; http://dx.doi.org/10.1093/infdis/jir390
84. Cardellino A, Khawaja S, Sánchez Cruz E, Mast TC. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method. Hum Vaccin Immunother 2013; 9:1449-53; PMID:23571175; http://dx.doi.org/10.4161/hv.24338
85. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, de Oliveira LH, Kerin T, Bowen M, Gentsch J, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340:c2825; PMID:20551120; http://dx.doi.org/10.1136/bmj.c2825
86. Mast TC, Khawaja S, Espinoza F, Paniagua M, Del Carmen LP, Cardellino A, Sánchez E. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua. Pediatr Infect Dis J 2011; 30:e209-15; PMID:21768920; http://dx.doi.org/10.1097/INF.0b013e31822a8527
87. Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, Gonzalez A, Malespin O, Amador JJ, Umaña J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-51; PMID:19491186; http://dx.doi.org/10.1001/ jama.2009.756
88. Patel M, Pedreira C, De Oliveira LH, Umaña J, Tate J, Lopman B, Sanchez E, Reyes M, Mercado J, Gonzalez A, et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012; 130:e365-72; PMID:22753550; http://dx.doi.org/10.1542/peds.2011-3478
89. Patel MM, Patzi M, Pastor D, Nina A, Roca Y, Alvarez L, Iniguez V, Rivera R, Tam KI, Quaye O, et al. Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ 2013; 346:f3726; PMID:23783434; http://dx.doi.org/10.1136/bmj.f3726
90. Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M, et al. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis 2012; 12:213; PMID:22974466; http://dx.doi.org/10.1186/1471-2334-12-213
91. Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis 2012; 12:561-70; PMID:22742639; http://dx.doi.org/10.1016/S1473-3099(12)70029-4
92. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, et al.; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344:564-72; PMID:11207352; http://dx.doi.org/10. 1056/NEJM200102223440804
93. Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE; PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29:3061-6; PMID:21316503; http://dx.doi.org/10.1016/j.vaccine.2011.01.088
94. Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364:2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952
95. Velázquez FR, Colindres RE, Grajales C, Hernández MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R, Ortega-Barria E, Blum M, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012; 31:736-44; PMID:22695189; http://dx.doi.org/10.1097/ INF.0b013e318253add3
96. World Health Organization. Rotavirus vaccine and intussusception:report from an expert consultation. Wkly Epidemiol Rec 2011; 86:317-21; PMID:21800466
97. Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med 2012; 9:e1001330; PMID:23109915; http://dx.doi.org/10.1371/journal.pmed. 1001330
98. Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014; 370:513-9; PMID:24422678; http://dx.doi.org/10.1056/NEJMoa1311738
99. Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med 2014; 370:503-12; PMID:24422676; http://dx.doi.org/10.1056/NEJMoa1303164
100. Glass RI, Parashar UD. Rotavirus vaccines - balancing intussusception risks and health benefits. N Engl J Med 2014; 370:568-70; PMID:24422677; http://dx.doi.org/10.1056/NEJMe1315836
101. World Health Organization. Vaccine introduction guidelines - adding a vaccine to a national immunization programme: decision and implementation. Geneva, Switzerland: WHO Document Services; 2003.
102. Australian Government Therapeutic Goods Administration. Rotavirus vaccination and risk of intussusception. 2011; http://www.tga.gov.au/safety/ alerts-medicine-rotavirus-110225.htm. Accessed August 24, 2011.
103. Cortese MM. Summary of intussusception risk and benefits of rotavirus vaccination in the United States. Adivsory Committee on Immunization Practices Meeting; June 20, 2013, 2013; Atlanta, GA.